There are few studies on the effect of bilirubin levels and/or of UGT1A1 gene polymorphism in the outcome of CVD in the general population, namely, in the development of coronary artery disease, coronary heart disease, peripheral vascular disease, and stroke. The gene discussed is UGT1A1; the disease is coronary artery disorder.